MAXCYTE, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Maxcyte, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Maxcyte, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 105M shares, a 1.61% increase year-over-year.
  • Maxcyte, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 103M shares, a 1.54% increase from 2022.
  • Maxcyte, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 102M shares, a 12.2% increase from 2021.
  • Maxcyte, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 90.6M shares, a 30.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 105M +1.66M +1.61% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 105M +1.58M +1.53% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 104M +1.24M +1.21% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 103M +1.57M +1.54% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 103M +1.64M +1.61% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 103M +1.64M +1.61% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 103M +1.54M +1.52% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 102M +11.1M +12.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 102M +6.14M +6.42% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 101M +16.7M +19.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 101M +20.3M +25.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 90.6M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 95.7M +18.6M +24.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 84.7M +18.9M +28.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 81M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 77.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 65.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.